Nexentis Technologies (NXTS) Stock Price, News & Analysis
Ticker history: NITO became NXTS (Nexentis Technologies Inc.) on . Earlier news and filings retain their original names and dates. View NITO history.
Why is NXTS Stock Down Today?
AI-generated explanation by Rhea-AI. How Rhea-AI works. Not financial advice.
What Changed
Price Move History
- Daily moves over 5%
- 100 252 sessions, November 5, 2025 to November 5, 2026
- Largest daily move
- +155.9% close of June 22, 2026
- 1-year change
- -97.8% closing prices, November 5, 2025 to November 5, 2026
- 1-month change
- -65.1% closing prices, October 5, 2026 to November 5, 2026
Company Description
Nexentis Technologies Inc. is a Nasdaq-listed operating company focused on biotechnology drug discovery and solar energy asset investments. The company describes itself as a drug discovery company that also invests in solar energy assets using a Ready to Build business model. Its common stock trades on the Nasdaq Capital Market under the symbol NXTS, and the company is incorporated in Nevada with corporate operations identified in Neve Yarak, Israel.
The company’s biotechnology activity is conducted through its wholly owned subsidiary, MitoCareX Bio Ltd. MitoCareX is focused on mitochondrial drug discovery, including therapeutic programs for inflammatory metabolic diseases and cancer that target specific metabolic pathways. Its proprietary algorithm platform, MITOLINE™, is a sequence analysis and alignment algorithm designed to prepare mitochondrial carrier proteins of the SLC25 family for 3D homology modeling. The platform is intended to address the lack of solved three-dimensional structures for many human mitochondrial carriers by aligning and annotating amino acid sequences and residues for comparative modeling.
Nexentis also reports an investment focus in solar energy assets based on the RTB model, which refers to projects that are ready to build. In addition, the company controls approximately 98% of Save Foods Ltd., an Israeli company focused on post-harvest treatment technologies designed to reduce pathogen contamination in fruits and vegetables.
The company’s public-company record includes capital-structure actions and shareholder approvals. In April 2026, Nexentis effected a one-for-seven reverse stock split of its common stock, after which the shares continued trading on Nasdaq under the NXTS symbol with a new CUSIP number. Its proxy and current-report disclosures also cover stockholder voting matters, Nasdaq Marketplace Rule 5635(d) equity-issuance approvals, material agreements, and amendments affecting common-stock rights.
Stock Performance
Nexentis Technologies (NXTS) closed at $0.4815 on November 5, 2026. Over the past 12 months, the price has lost 97.8%.
NXTS Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Nexentis Technologies has 10 recent news articles, with the latest published today. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include stock split, AI, management. View all NXTS news →
SEC Filings
Nexentis Technologies has filed 10 recent SEC filings, including 8 Form 4, 1 Form PRE 14A, 1 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all NXTS SEC filings →
Financial Highlights
Nexentis Technologies reported operating income of -$4.2M in FY2025, and net income was -$4.0M. Diluted earnings per share stood at -$8.61. The company generated -$3.8M in operating cash flow. The current ratio was 4.19, measuring current assets divided by current liabilities.
Upcoming Events
Reverse stock split
Nexentis Technologies has 1 upcoming scheduled event. The next event, "Reverse stock split", is scheduled for November 9, 2026 (in 4 days). Investors can track these dates to stay informed about potential catalysts that may affect the NXTS stock price.
Short Interest History
Short interest in Nexentis Technologies (NXTS) currently stands at 61.3 thousand shares, up 62.4% from the previous reporting period, representing 5.3% of the float. Since the latest stock split, short interest has increased by 166.3%, measured from April 2026.
Days to Cover History
Days to cover for Nexentis Technologies (NXTS) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 2.3 days.
NXTS Company Profile & Sector Positioning
Nexentis Technologies (NXTS) operates in the Agricultural Inputs industry within the broader Basic Materials sector and is listed on the NASDAQ.
Investors comparing NXTS often look at related companies in the same sector, including Bioceres Crop Solutions Corp. (BIOX), Origin Agritech Limited (SEED), American Vanguard Corporation (AVD), CVR Partners, LP (UAN), and FMC Corporation (FMC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NXTS's relative position within its industry.
Nexentis Technologies (NXTS) approved a 1-for-5 reverse stock split scheduled to take effect for Nasdaq purposes on November 9, 2026.
Split-adjusted trading will begin that day on the Nasdaq Capital Market under the unchanged symbol NXTS. Every five outstanding common shares will become one share, reducing outstanding shares from approximately 2.9 million to approximately 600 thousand. Authorized common shares will remain unchanged. The company gives regaining compliance with Nasdaq’s continued listing requirements and attracting certain institutional investors as reasons for the reverse split authorization.